The core activity of Glarustherapie is the diagnosis and treatment of chronic diseases, particularly chronic pain, Meniere's disease, polyneuropathy and chronic gastrointestinal disorders, using a special, non-invasive and sustainable therapy approach based on the analysis of electrical signals in the body, which supports the body's natural regeneration.
AI-generated
Offering
Products & services
Industry:Naturopathic Clinics
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Non-invasive diagnosis and treatment of chronic diseases using mechanical and electrical impulse delivery; individual anamnesis, identification of causes and therapy for chronic symptom conditions.
Treatment of chronic pain
Anamnesis, diagnostics and non-invasive therapy for chronic pain, pain syndromes, back pain, joint and headache pain as well as migraine.
Ménière’s disease therapy
Assessment and non-invasive treatment of Ménière’s disease with vertigo attacks, tinnitus and hearing impairment; individual diagnostics and treatment planning.
Polyneuropathy treatment
Diagnostics and alternative therapy for polyneuropathy and nerve damage with tingling, numbness, burning sensations, pain and restricted movement.
Alternative pain therapy
Alternative, non-invasive pain treatment for chronic pain conditions when conventional treatments do not help; individual treatment with Glarus Therapie.
Therapy for chronic intestinal disorders
Treatment of chronic gastrointestinal diseases such as Crohn’s disease, ulcerative colitis and irritable bowel syndrome; non-invasive therapy, diagnostics and clarification of causes.
Comparisons
Sana Biotech AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Sana Biotech AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Sana Biotech AG has claimed this profile, we'll publish editorial articles and case studies here together.